T cell receptor induced intracellular redistribution of type I protein kinase A

Immunology

Volumn 113, Issue 4, 2004, Pages 453-459

  Zhou, Wenhong ^a   Vergara, Leoncio ^b   König, Rolf ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Cellular localization; Confocal microscopy; Signal transduction; T lymphocytes

Indexed keywords

CD3 ANTIGEN; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE TYPE 1; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN ANTIBODY COMPLEX; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LOCALIZATION; LASER MICROSCOPY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE MEMBRANE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD3; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; CYCLIC AMP-DEPENDENT PROTEIN KINASES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; MICROSCOPY, CONFOCAL; RECEPTORS, ANTIGEN, T-CELL;

EID: 9944245495     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2004.01992.x     Document Type: Article

References (47)

1. Walsh DA, Perkins JP, Krebs EG. An adenosine 3′,5′- monophosphate-dependent protein kinase from rabbit skeletal muscle. J Biol Chem 1968; 243:3763-5.
2. Walsh DA, Van Patten SM. Multiple pathway signal transduction by the cAMP-dependent protein kinase. Faseb J 1994; 8:1227-36.
3. Corbin JD, Sugden PH, West L, Flockhart DA, Lincoln TM, McCarthy D. Studies on the properties and mode of action of the purified regulatory subunit of bovine heart adenosine 3′,5′-monophosphate-dependent protein kinase. J Biol Chem 1978; 253:3997-4003.
4. Doskeland SO, Ogreid D. Binding proteins for cyclic AMP in mammalian tissues. Int J Biochem 1981; 13:1-19.
5. Doskeland SO, Maronde E, Gjertsen BT. The genetic subtypes of cAMP-dependent protein kinase - functionally different or redundant? Biochim Biophys Acta 1993; 1178:249-58.
6. Robinson-Steiner AM, Corbin JD. Probable involvement of both intrachain cAMP binding sites in activation of protein kinase. J Biol Chem 1983; 258:1032-40.
7. Houge G, Steinberg RA, Ogreid D, Doskeland SO. The rate of recombination of the subunits (RI and C) of cAMP-dependent protein kinase depends on whether one or two cAMP molecules are bound per RI monomer. J Biol Chem 1990; 265:19507-16.
8. Meinkoth JL, Ji Y, Taylor SS, Feramisco JR. Dynamics of the distribution of cyclic AMP-dependent protein kinase in living cells. Proc Natl Acad Sci USA 1990; 87:9595-9.
9. Hasler P, Moore JJ, Kammer GM. Human T lymphocyte cAMP-dependent protein kinase. subcellular distributions and activity ranges of type I and type II isozymes. Faseb J 1992; 6:2735-41.
10. Skålhegg BS, Taskén K, Hansson V, Huitfeldt HS, Jahnsen T, Lea T. Location of cAMP-dependent protein kinase type I with the TCR-CD3 complex. Science 1994; 263:84-7.
11. Johnson LR, Foster JA, Haig-Ladewig L, VanScoy H, Rubin CS, Moss SB, Gerton GL. Assembly of AKAP82, a protein kinase A anchor protein, into the fibrous sheath of mouse sperm. Dev Biol 1997; 192:340-50.
12. Reinton N, Collas P, Haugen TB, Skålhegg BS, Hansson V, Jahnsen T, Taskén K. Localization of a novel human A-kinase-anchoring protein, hAKAP220, during spermatogenesis. Dev Biol 2000; 223:194-204.
13. Scott JD, Stofko RE, McDonald JR, Comer JD, Vitalis EA, Mangili JA. Type II regulatory subunit dimerization determines the subcellular localization of the cAMP-dependent protein kinase. J Biol Chem 1990; 265:21561-6.
14. Scott JD, McCartney S. Localization of A-kinase through anchoring proteins. Mol Endocrinol 1994; 8:5-11.
15. Theurkauf WE, Vallee RB. Molecular characterization of the cAMP-dependent protein kinase bound to microtubule-associated protein 2. J Biol Chem 1982; 257:3284-90.
16. Skålhegg BS, Landmark BF, Doskeland SO, Hansson V, Lea T, Jahnsen T. Cyclic AMP-dependent protein kinase type I mediates the inhibitory effects of 3′,5′-cyclic adenosine monophos-phate on cell replication in human T lymphocytes. J Biol Chem 1992; 267:15707-14.
17. Aukrust P, Aandahl EM, Skålhegg BS, Nordoy I, Hansson V, Taskén K, Froland SS, Muller F. Increased activation of protein kinase A type I contributes to the T cell deficiency in common variable immunodeficiency. J Immunol 1999; 162:1178-85.
18. Aandahl EM, Moretto WJ, Haslett PA, Vang T, Bryn T, Taskén K, Nixon DF. Inhibition of antigen-specific T cell proliferation and cytokine production by protein kinase A type I. J Immunol 2002; 169:802-8.
19. Vang T, Torgersen KM, Sundvold V et al. Activation of the COOH-terminal Src kinase (Csk) by cAMP-dependent protein kinase inhibits signaling through the T cell receptor. J Exp Med 2001; 193:497-507.
20. Ramstad C, Sundvold V, Johansen HK, Lea T. cAMP-dependent protein kinase (PKA) inhibits T cell activation by phosphorylating ser-43 of raf-1 in the MAPK/ERK pathway. Cell Signal 2000; 12:557-63.
21. Chen D, Rothenberg EV. Interleukin 2 transcription factors as molecular targets of cAMP inhibition: delayed inhibition kinetics and combinatorial transcription roles. J Exp Med 1994; 179:931-42.
22. van Oirschot BA, Stahl M, Lens SM, Medema RH. Protein kinase A regulates the expression of p27 (kip1) and cyclin D3 to suppress proliferation of leukemic T cell lines. J Biol Chem 2001; 276:33854-60.
23. Matsushime H, Roussel MF, Ashmun RA, Sherr CJ. Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell 1991; 65:701-13.
24. kip1 expression in human peripheral T lymphocytes. Eur J Immunol 1999; 29:789-98.
25. Meyerson M, Harlow E. Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol Cell Biol 1994; 14:2077-84.
26. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell 1995; 81:323-30.
27. kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 1994; 372:570-3.
28. Firpo EJ, Koff A, Solomon MJ, Roberts JM. Inactivation of a Cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes. Mol Cell Biol 1994; 14:4889-990.
29. Vang T, Abrahamsen H, Myklebust S, Horejsi V, Taskén K. Combined spatial and enzymatic regulation of Csk by cAMP and protein kinase a inhibits T cell receptor signaling. J Biol Chem 2003; 278:17597-600.
30. Laxminarayana D, Berrada A, Kammer GM. Early events of human T lymphocyte activation are associated with type I protein kinase A activity. J Clin Invest 1993; 92:2207-14.
31. Munoz E, Zubiaga AM, Merrow M, Sauter NP, Huber BT. Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: role of cAMP in T cell proliferation. J Exp Med 1990; 172:95-103.
32. Zhou W, König R. T cell receptor-independent CD4 signalling. CD4-MHC class II interactions regulate intracellular calcium and cyclic AMP. Cell Signal 2003; 15:751-62.
33. Monks CR, Freiberg BA, Kupfer H, Sciaky N, Kupfer A. Three-dimensional segregation of supramolecular activation clusters in T cells. Nature 1998; 395:82-6.
34. Grakoui A, Bromley SK, Sumen C, Davis MM, Shaw AS, Allen PM, Dustin ML. The immunological synapse: a molecular machine controlling T cell activation. Science 1999; 285:221-7.
35. + T lymphocytes in transgenic mice expressing mutant MHC class II molecules deficient in their interaction with CD4. J Immunol 1998; 161:6629-37.
36. + T lymphocytes in vitro and in vivo. J Immunol 1996; 157:87-100.
37. Allenspach EJ, Cullinan P, Tong J et al. ERM-dependent movement of CD43 defines a novel protein complex distal to the immunological synapse. Immunity 2001; 15:739-50.
38. König R, Huang LY, Germain RN. MHC class II interaction with CD4 mediated by a region analogous to the MHC class I binding site for CD8. Nature 1992; 356:796-8.
39. lck). Mol Cell Biol 1988; 8:540-50.
40. lck through mutation of a regulatory carboxy-terminal tyrosine residue requires intact sites of autophosphorylation and myristylation. Mol Cell Biol 1990; 10:5197-206.
41. Pryzwansky KB, Steiner AL, Spitznagel JK, Kapoor CL. Compartmentalization of cyclic AMP during phagocytosis by human neutrophilic granulocytes. Science 1981; 211:407-10.
42. Pryzwansky KB, Kidao S, Merricks EP. Compartmentalization of PDE-4 and cAMP-dependent protein kinase in neutrophils and macrophages during phagocytosis. Cell Biochem Biophys 1998; 28:251-75.
43. Krummel MF, Sjaastad MD, Wulfing C, Davis MM. Differential clustering of CD4 and CD3zeta during T cell recognition. Science 2000; 289:1349-52.
44. Delon J, Kaibuchi K, Germain RN. Exclusion of CD43 from the immunological synapse is mediated by phosphorylation-regulated relocation of the cytoskeletal adaptor moesin. Immunity 2001; 15:691-701.
45. Monks CR, Kupfer H, Tamir I, Barlow A, Kupfer A. Selective modulation of protein kinase C-theta during T-cell activation. Nature 1997; 385:83-6.
46. Huang LJ, Durick K, Weiner JA, Chun J, Taylor SS. Identification of a novel protein kinase A anchoring protein that binds both type I and type II regulatory subunits. J Biol Chem 1997; 272:8057-64.
47. Skålhegg BS, Taskén K. Specificity in the cAMP/PKA signaling pathway. Differential expression, regulation, and subcellular localization of subunits of PKA. Front Biosci 2000; 5:D678-93.